{
  "id": "56c85ed65795f9a73e000012",
  "type": "factoid",
  "question": "Does dasatinib promote or inhibit T-cell proliferation?",
  "ideal_answer": "Dasatinib inhibits T-cell proliferation",
  "documents": [
    "http://www.ncbi.nlm.nih.gov/pubmed/19066329",
    "http://www.ncbi.nlm.nih.gov/pubmed/18395492",
    "http://www.ncbi.nlm.nih.gov/pubmed/17962511",
    "http://www.ncbi.nlm.nih.gov/pubmed/19056158",
    "http://www.ncbi.nlm.nih.gov/pubmed/18619726",
    "http://www.ncbi.nlm.nih.gov/pubmed/19016717",
    "http://www.ncbi.nlm.nih.gov/pubmed/18413841"
  ],
  "snippets": [
    {
      "text": "Dasatinib inhibited antigen-specific proliferation of murine CD4(+) and CD8(+) transgenic T cells in vitro and in vivo",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/19056158",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": "Herein, we show that dasatinib inhibits TCR-mediated signal transduction, cellular proliferation, cytokine production, and in vivo T-cell responses. ",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/17962511",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": "Both dasatinib and staurosporine inhibited T-cell activation, proliferation, cytokine production, and degranulation in a dose-dependent manner. ",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/18413841",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": "Herein, we show that dasatinib inhibits TCR-mediated signal transduction, cellular proliferation, cytokine production, and in vivo T-cell responses",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/17962511",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": "Dasatinib, a small-molecule protein tyrosine kinase inhibitor, inhibits T-cell activation and proliferation",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/17962511",
      "beginSection": "title",
      "endSection": "title"
    },
    {
      "text": "Dasatinib, a small-molecule protein tyrosine kinase inhibitor, inhibits T-cell activation and proliferation.",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/17962511",
      "beginSection": "title",
      "endSection": "title"
    },
    {
      "text": "Dasatinib inhibits the proliferation and function of CD4+CD25+ regulatory T cells.",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/19016717",
      "beginSection": "title",
      "endSection": "title"
    },
    {
      "text": "T-cell functions including proliferation, activation and cytokine production were all uniformly inhibited in the presence of dasatinib. We also demonstrated inhibition of TCR signalling through Src-family kinase LCK, and predicted that inhibition of LCK and other kinases involved in T-cell signalling by dasatinib is responsible for the suppression of T-cell function. ",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/18395492",
      "beginSection": "abstract",
      "endSection": "abstract"
    }
  ],
  "concepts": [
    "http://www.biosemantics.org/jochem#4274027",
    "http://amigo.geneontology.org/amigo/term/GO:0042098",
    "http://amigo.geneontology.org/amigo/term/GO:0042130",
    "http://amigo.geneontology.org/amigo/term/GO:0042102",
    "http://www.nlm.nih.gov/cgi/mesh/2016/MB_cgi?field=uid&exact=Find+Exact+Term&term=D000069439",
    "http://www.biosemantics.org/jochem#4244012",
    "http://www.biosemantics.org/jochem#http://www.biosemantics.org/jochem#:4274027"
  ],
  "exact_answer": "inhibits"
}